Reverse Medical has received CE mark for its RePort Guide Catheter System, intended to provide intracranial access during interventional neurovascular procedures.

Reverse Medical said that the RePort Guide Catheter System provides the neurovascular specialist with a new tool that can navigate deeply into the cerebral vascular anatomy, enabling them to treat more patients than with currently available technologies.

The California-based neurovascular devices firm has been working to expand its technology platform to include treatments for a broad spectrum of neurovascular disorders and carotid artery disease.

Satoshi Tateshima, scientific and clinical advisor of Reverse Medical, UCLA Interventional Neuroradiology, Ronald Reagan UCLA Medical Center, said: “The neurovascular anatomy often presents challenges related to fundamental access, and deep brain therapeutic microcatheter navigation support.

“The RePort Guide Catheter System design represents a game changing advancement over other guide catheters available today. The system is designed to be used across a broad range of neuro interventional procedures.

“The RePort Guide Catheter System has been designed to enable placement beyond the skull base more easily and safely than other currently available devices. I look forward to its US commercial availability in the future.”

Jeffrey Valko, president and chief executive officer of Reverse Medical, said: “The timing for the RePort Guide Catheter System regulatory approval is perfect as access to the deep neurovascular anatomy is a current focus of neuro interventionalists’ interest.

“The various RePort Guide Catheter System models will enable physicians to treat a broader group of patients, helping to increase patient throughput and to enhance the economic viability of neuro labs and stroke centers worldwide. The company plans to commence commercialization during 2010.”